PDF下载 ( 112 KB)
Liver fat deposition and the pathogenesis of diabetes mellitus
-
-
[1]Angulo P.Nonalcoholic fatty liver disease[J].N Engl J Med, 2002, 346 (16) :1221-1231. [2]Park SH, Jeon WK, Kim SH, et al.Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults[J].J Gastro-enterol Hepatol, 2006, 21 (1) :138-143. [3]Fan JG, Zhu J, Li XJ, et al.Fatty liver and the metabolic syndrome among Shanghai adults[J].J Gastroenterol Hepatol, 2005, 20 (12) :1825-1832. [4]Nannipieri M, Gonzales C, Baldi S, et al.Liver Enzymes, the Meta-bolic Syndrome, and Incident Diabetes:the Mexico City diabetes study[J].Diabetes Care, 2005, 28 (7) :1757-1762. [5]刘蒙, 颜红梅, 高鑫, 等.非酒精性脂肪性肝病患者中肝酶与代谢综合征的关系[J].中华医学杂志, 2007, 87 (4) :253-255. [6]Vozarova B, Stefan N, Lindsay RS, et al.High alanine aminotrans-ferase is associated with decreased hepatic insulin sensitivity and pre-dicts the development of type2diabetes[J].Diabetes, 2002, 51 (6) :1889-1895. [7]Sattar N, Scherbakova O, Ford I, et al.Elevated alanine amin-otransferase predicts new-onset type2diabetes independently of classical risk factors, metabolic syndrome, and c-reactive protein in the west of scotland coronary prevention study[J].Diabetes, 2004, 53 (11) :2855-2860. [8]Hanley AJ, Williams K, Festa A, et al.Insulin resistance athero-sclerosis study.Elevations in markers of liver injury and risk of type2diabetes:the insulin resistance atherosclerosis study[J].Diabe-tes, 2004, 53 (10) :2623-2632. [9]Browning JD, Szczepaniak LS, Dobbins R, et al.Prevalence of he-patic steatosis in an urban population in the United States:impact of ethnicity[J].Hepatology, 2004, 40 (6) :1387-1395. [10]Szczepaniak LS, Nurenberg P, Leonard D, et al.Magnetic reso-nance spectroscopy to measure hepatic triglyceride content:preva-lence of hepatic steatosis in the general population[J].Am J Physiol Endocrinol Metab, 2005, 288 (2) :E462-468. [11]刘蒙, 高鑫.质子磁共振波谱分析定量检测肝脏脂肪含量方法的建立与临床应用[J].中华医学杂志, 2008, 88 (8) :531-533. [12]Petersen KF, Gerald I.Shulman GI Newinsights into the pathogen-esis of insulin resistance in humans using magnetic resonance spec-troscopy[J].Obesity, 2006, 14 (Suppl1) :34S-40S. [13]Reaven GM.Banting lecture1988.Role of insulin resistance in hu-man disease[J].Diabetes, 1988, 37 (12) :1595-1607. [14]Marchesini G, Bugianesi E, Forlani G, et al.Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome[J].Hepatology, 2003, 37 (4) :917-923. [15]Ali R, Cusi K.New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD) [J].Annals of Medicine, 2009, 41 (4) :265-278. [16]Clark JM, Brancati FL, Diehl AM.The prevalence and etiology of elevated aminotransferase levels in the United States[J].Am J Gas-troenterol, 2003, 98 (5) :960-967. [17]Angulo P.GI Epidemiology:nonalcoholic fatty liver disease[J].Aliment Pharmacol Ther, 2007, 25 (8) :883-889. [18]Cheung O, Sanyal AJ.Recent advances in nonalcoholic fatty liver disease[J].Curr Opin Gastroenterol, 2009, 25 (3) :230-237. -
本文二维码
计量
- 文章访问数: 3212
- HTML全文浏览量: 2
- PDF下载量: 960
- 被引次数: 0
下载:
